Star Cement (540575) Q4 15/16 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 15/16 earnings summary
26 Oct, 2026Executive summary
FY2015-16 consolidated revenue was ₹1,716.33 crore, up 20%; cement sales volume rose 21.2% to 2.63 million MT.
EBITDA declined 8% to ₹400.69 crore amid weaker realizations and higher input costs; PAT increased 13% to ₹134.04 crore, aided by lower depreciation.
Production growth and lower leverage supported performance despite subdued cement demand, falling prices and cost pressure across the industry.
Financial highlights
Consolidated net sales were ₹1,715.03 crore versus ₹1,430.43 crore in FY2014-15, up 19.8%; total revenue was ₹1,716.33 crore.
Consolidated EBITDA was ₹400.69 crore versus ₹437.23 crore; PBT rose to ₹145.30 crore from ₹126.12 crore and PAT to ₹134.04 crore from ₹118.65 crore.
Consolidated cement production increased 23% to 2,670,287 MT; sales volume rose 21.2% to 2,629,695 MT.
Net worth grew 14.55% to ₹1,055.34 crore; reported revenue growth was 19.71%.
Outlook and guidance
Management expected operational performance to improve in FY2016-17 as the economic outlook strengthened.
Strategic priorities included expanding capacity, growing outside the North-East and steadily reducing debt with a long-term aim of becoming debt-free.
Indian cement demand was forecast to grow 6% in FY2016-17 and 7% in FY2017-18; planned industry capacity additions were 16 MTPA and 8 MTPA, respectively.
Latest events from Star Cement
- Revenue rose, consolidated profit fell, and the ₹1,500 crore fund raise was deferred.540575
Q2 26/27 - Record FY10 earnings and expansion plans face rising input-cost pressure.540575
Q4 09/10 - Record output and expansion plans countered cost pressure and softer consolidated profits.540575
Q4 10/11 - Volume gains and expansion advanced despite falling profits and surging costs.540575
Q4 11/12 - New capacity and market expansion plans amid sharply lower profit and rising costs.540575
Q4 12/13 - New capacity drove rapid growth, but higher financing and depreciation costs kept FY14 in loss.540575
Q4 13/14 - Sales volume rose 33% and EBITDA 85% as capacity expansion drove growth.540575
Q4 14/15 - Record profits and sharp debt reduction set the stage for capacity-led growth.540575
Q4 17/18 - Profit rose despite a weak market, while regional sales and capacity expansion advanced.540575
Q4 16/17